|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6885 USD | +5.11% |
|
-5.72% | +3.69% |
Aligos Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.14 million. Net loss was USD 22.96 million compared to USD 35.62 million a year ago.
Basic loss per share from continuing operations was USD 0.53 compared to USD 0.84 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.69% | 5.38Cr | |
| +33.63% | 5.09TCr | |
| -0.09% | 4.21TCr | |
| +49.62% | 4.2TCr | |
| -4.96% | 2.92TCr | |
| +11.18% | 2.6TCr | |
| -21.95% | 1.89TCr | |
| +8.61% | 1.32TCr | |
| +28.31% | 1.22TCr | |
| +24.73% | 1.22TCr |
ALIGOS THERAPEUTICS, INC. 
